{"id":"https://openalex.org/W1978160128","doi":"https://doi.org/10.1016/s0168-8278(10)61204-4","title":"2013 ANTIVIRAL ACTIVITY, PHARMACOKINETICS AND SAFETY OF IDX184 IN COMBINATION WITH PEGYLATED INTERFERON (PEGIFN) AND RIBAVIRIN (RBV) IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED SUBJECTS","display_name":"2013 ANTIVIRAL ACTIVITY, PHARMACOKINETICS AND SAFETY OF IDX184 IN COMBINATION WITH PEGYLATED INTERFERON (PEGIFN) AND RIBAVIRIN (RBV) IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED SUBJECTS","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W1978160128","doi":"https://doi.org/10.1016/s0168-8278(10)61204-4","mag":"1978160128"},"language":"en","primary_location":{"id":"doi:10.1016/s0168-8278(10)61204-4","doi":"https://doi.org/10.1016/s0168-8278(10)61204-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-8278(10)61204-4","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002916327","display_name":"Jacob Paul Lalezari","orcid":"https://orcid.org/0000-0002-2744-4918","observed_orcids":["https://orcid.org/0000-0002-2744-4918"]},"institutions":[{"id":"https://openalex.org/I4210101066","display_name":"Quest Clinical Research (United States)","ror":"https://ror.org/019mfbd19","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Lalezari","raw_affiliation_strings":["Quest Clinical Research, San Francisco,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Clinical Research, San Francisco,","institution_ids":["https://openalex.org/I4210101066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024023232","display_name":"F. Fred Poordad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"F. Poordad","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles,","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109115621","display_name":"Prachi Mehra","orcid":"https://orcid.org/0009-0009-2792-7643","observed_orcids":["https://orcid.org/0009-0009-2792-7643"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Mehra","raw_affiliation_strings":["eStudySite, 4 Tuan Trong Nguyen, MD, San Diego, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eStudySite, 4 Tuan Trong Nguyen, MD, San Diego, CA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102002403","display_name":"Tuyet Thi Nguyen","orcid":"https://orcid.org/0000-0002-2686-6895","observed_orcids":["https://orcid.org/0000-0002-2686-6895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Nguyen","raw_affiliation_strings":["Investigator Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigator Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107827400","display_name":"E DeJesus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120784","display_name":"Orlando Immunology Center","ror":"https://ror.org/02cj88v79","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210120784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Dejesus","raw_affiliation_strings":["Orlando Immunology Center, Orlando,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando Immunology Center, Orlando,","institution_ids":["https://openalex.org/I4210120784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020883261","display_name":"Eliot W. Godofsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136161","display_name":"Bach & Godofsky Infectious Diseases","ror":"https://ror.org/04ej3kx94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210136161"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Godofsky","raw_affiliation_strings":["University Hepatitis Center at Bach & Godofsky, M.D., P.A., Sarasota, FL,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hepatitis Center at Bach & Godofsky, M.D., P.A., Sarasota, FL,","institution_ids":["https://openalex.org/I4210136161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073947773","display_name":"Gloria Dubuc-Patrick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Dubuc Patrick","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028577000","display_name":"J. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Chen","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027950312","display_name":"Keith Pietropaolo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Pietropaolo","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100715700","display_name":"Xuan Zhou","orcid":"https://orcid.org/0000-0002-7884-9018","observed_orcids":["https://orcid.org/0000-0002-7884-9018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X.-J. Zhou","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010049732","display_name":"JOHN Z. SULLIVAN-BOLYAI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.Z. Sullivan-B\u00f3lyai","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111932686","display_name":"Douglas L. Mayers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Mayers","raw_affiliation_strings":["Idenix Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idenix Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024023232"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.6043,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.89047678,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"52","issue":null,"first_page":"S469","last_page":"S469"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sofosbuvir","display_name":"sofosbuvir","score":0.6610000133514404},{"id":"https://openalex.org/keywords/peginterferon-alfa-2b","display_name":"peginterferon alfa-2b","score":0.8100000023841858},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.625},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8960000276565552},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9449999928474426}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.8887956738471985},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.7047821879386902},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6247475147247314},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.48619717359542847},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.41005176305770874},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.408136248588562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3661620318889618},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3581621050834656},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.12362554669380188}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0168-8278(10)61204-4","doi":"https://doi.org/10.1016/s0168-8278(10)61204-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-8278(10)61204-4","pdf_url":null,"source":{"id":"https://openalex.org/S83651209","display_name":"Journal of Hepatology","issn_l":"0168-8278","issn":["0168-8278","1600-0641"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hepatology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2057185040","https://openalex.org/W2249900850","https://openalex.org/W7015630319","https://openalex.org/W2063638629","https://openalex.org/W2023701061","https://openalex.org/W1974517883","https://openalex.org/W2042713943","https://openalex.org/W2055919428","https://openalex.org/W1976834322","https://openalex.org/W7038539680"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}